George Michalopoulos, MD, PhD
George K. Michalopoulos, MD, PhD was born on the island of Samos, Greece. He graduated from Athens University Medical School in 1969 and completed his residency as well as studies for the PhD in Oncology at the University of Wisconsin (Madison).
Dr. Michalopoulos spent 14 years at Duke University as a liver pathologist and NIH-funded investigator of liver regeneration. Prior to leaving Duke, his laboratory was the first to identify and isolate Hepatocyte Growth Factor (HGF) and its receptor c-Met. He joined the University of Pittsburgh as chair of the Department of Pathology in 1991.
Dr. Michalopoulos is continuing to study liver regeneration along with concentrating on administering the Department of Pathology. He is the recipient of an NIH Merit Award and the recipient of the 2009 Rous-Whipple Award in Experimental Pathology. His current studies concentrate on the role of extracellular matrix, HGF and EGF receptors as determinants of liver growth. He is also studying the mechanisms by which hepatocytes and biliary cells become facultative stem cells for each other. Dr. Michalopoulos has been a member of the Council of the Association of Pathology Chairs, and led the Research Committee of that group for six years. He is also a member of the NIH Liver Biology Advisory Board and Chair of the Scientific Advisory Board of NIAAA, one of the NIH institutes.
Continuing Medical Education
The University of Pittsburgh School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Other health care professionals are awarded 0.10 continuing education units (CEUs) which are equal to 1.0 contact hours.